Jill A. Fisher - Böcker

Today, more than 75 percent of pharmaceutical drug trials in the United States are being conducted in the private sector. Once the sole province of academic researchers, these important studies are now being outsourced to non-academic physicians.According to Jill A. Fisher, this major change in the way medical research is performed is the outcome of two problems in U.S. health care: decreasing revenue for physicians and decreasing access to treatment for patients. As physicians report diminishing income due to restrictive relationships with insurers, increasing malpractice insurance premiums, and inflated overhead costs to operate private practices, they are attracted to pharmaceutical contract research for its lucrative return. Clinical trials also provide limited medical access to individuals who have no or inadequate health insurance because they offer "free" doctors' visits, diagnostic tests, and medications to participants. Focusing on the professional roles of those involved, as well as key research practices, Fisher assesses the risks and advantages for physicians and patients alike when pharmaceutical drug studies are used as an alternative to standard medical care.A volume in the Critical Issues in Health and Medicine series, edited by Rima D. Apple and Janet Golden

How does contemporary science contribute to our understanding about what it means to be women or men? What are the social implications of scientific claims about differences between "male" and "female" brains, hormones, and genes? How does culture influence scientific and medical research and its findings about human sexuality, especially so-called normal and deviant desires and behaviors? Gender and the Science of Difference examines how contemporary science shapes and is shaped by gender ideals and images. Prior scholarship has illustrated how past cultures of science were infused with patriarchal norms and values that influenced the kinds of research that was conducted and the interpretation of findings about differences between men and women. This interdisciplinary volume presents empirical inquiries into today's science, including examples of gendered scientific inquiry and medical interventions and research. It analyzes how scientific and medical knowledge produces gender norms through an emphasis on sex differences, and includes both U.S. and non-U.S. cases and examples.

How does contemporary science contribute to our understanding about what it means to be women or men? What are the social implications of scientific claims about differences between "male" and "female" brains, hormones, and genes? How does culture influence scientific and medical research and its findings about human sexuality, especially so-called normal and deviant desires and behaviors? Gender and the Science of Difference examines how contemporary science shapes and is shaped by gender ideals and images. Prior scholarship has illustrated how past cultures of science were infused with patriarchal norms and values that influenced the kinds of research that was conducted and the interpretation of findings about differences between men and women. This interdisciplinary volume presents empirical inquiries into today's science, including examples of gendered scientific inquiry and medical interventions and research. It analyzes how scientific and medical knowledge produces gender norms through an emphasis on sex differences, and includes both U.S. and non-U.S. cases and examples.

Winner, 2022 Donald W. Light Award for Applied Medical Sociology, given by the Medical Sociology Section of the American Sociological AssociationWinner, 2021 Robert K. Merton Book Award, given by the Science, Knowledge, and Technology Section of the American Sociological Association2021 Outstanding Academic Title, Choice Magazine Explores the social inequality of clinical drug testing and its effects on scientific resultsImagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to $5,175. You must spend twenty nights literally locked in a research facility. You will be told what to eat, when to eat, and when to sleep. You will share a bedroom with several strangers. Who are you, and why would you choose to take part in this kind of study? This book explores the hidden world of pharmaceutical testing on healthy volunteers. Drawing on two years of fieldwork in clinics across the country and 268 interviews with participants and staff, it illustrates how decisions to take part in such studies are often influenced by poverty and lack of employment opportunities. It shows that healthy participants are typically recruited from African American and Latino/a communities, and that they are often serial participants, who obtain a significant portion of their income from these trials. This book reveals not only how social inequality fundamentally shapes these drug trials, but it also depicts the important validity concerns inherent in this mode of testing new pharmaceuticals. These highly controlled studies bear little resemblance to real-world conditions, and everyone involved is incentivized to game the system, ultimately making new drugs appear safer than they really are. Adverse Events provides an unprecedented view of the intersection of racial inequalities with pharmaceutical testing, signaling the dangers of this research enterprise to both social justice and public health.